Use of bisphosphonates for the treatment of bone metastasis in experimental animal models
- 31 October 1999
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 25 (5) , 293-299
- https://doi.org/10.1053/ctrv.1999.0133
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Bisphosphonates as Anticancer DrugsNew England Journal of Medicine, 1998
- Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.Journal of Clinical Oncology, 1998
- Bisphosphonates in multiple myelomaCancer, 1997
- Bisphosphonates and breast carcinomaCancer, 1997
- Bisphosphonates in prostate carcinomaCancer, 1997
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Mechanisms of preferential metastasis of breast cancer to bone - (Review)International Journal of Oncology, 1996
- Management of Myeloma with BisphosphonatesNew England Journal of Medicine, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Journal of Clinical Investigation, 1991